Results of a Pilot Program to Improve Phosphorus Outcomes in Hemodialysis Patients

Results of a Pilot Program to Improve Phosphorus Outcomes in Hemodialysis Patients

Objective End-stage renal disease causes dysregulation of bone and mineral metabolism, including increased serum phosphorus levels. Kidney Foundation Kidney Disease Outcome Quality Initiative 2003 guidelines recommend maintaining phosphorus levels between 3.5 and 5.5 mg/dL in dialysis patients. We e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of renal nutrition 2012-09, Vol.22 (5), p.472-479
Hauptverfasser: Mayne, Tracy J., PhD, Benner, Debbie, MA, RD, CSR, Ricketts, Kathy, MS, RD, LDN, Burgess, Mary, MS, RD, Wilson, Steve, PhD, Poole, Lynne, MSc, Smyth, Michael, MRCGP, FRCS, Colson, Carey, MS, Krishnan, Mahesh, MD, MBA, MPH
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Bone and Bones - metabolism
Calcium - blood
Female
Humans
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Lanthanum - therapeutic use
Male
Middle Aged
Minerals - metabolism
Nephrology
Nutritional Status
Parathyroid Hormone - blood
Phosphorus - blood
Pilot Projects
Prospective Studies
Renal Dialysis
Serum Albumin - analysis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective End-stage renal disease causes dysregulation of bone and mineral metabolism, including increased serum phosphorus levels. Kidney Foundation Kidney Disease Outcome Quality Initiative 2003 guidelines recommend maintaining phosphorus levels between 3.5 and 5.5 mg/dL in dialysis patients. We examined the effects of a focused phosphorus management pilot program designed to improve the percentage of hemodialysis patients achieving phosphorus levels
ISSN:1051-2276
1532-8503
DOI:10.1053/j.jrn.2011.08.006